MedPath

Effect on Ocular Surface Symptoms of Online Education

Completed
Conditions
Ocular Surface Disease
Eye Diseases
Dry Eye
Registration Number
NCT04960696
Lead Sponsor
Kahramanmaras Sutcu Imam University
Brief Summary

retrospective, observational study.

Detailed Description

Aim: The aim of this study was to investigate the effects on ocular surface symptoms of students taking online education, which was a part of the distance learning model during the COVID-19 pandemic, to be able to prevent the formation of irreversible damage with early diagnosis and treatment. With recommendations that can be simply applied, it was aimed to protect ocular health.

Material and Method: The study included 315 students who were undertaking online education and presented at the Ophthalmology Department of a tertiary level university hospital. A record was made of sociodemographic data, Schirmer test results, tear break-up time (TBUT) measurements, and Ocular Surface Disease Index (OSDI) scores. The data were analyzed statistically using SPSS vn. 22.0 software, and a value of p\<0.05 was accepted as statistically significant.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
315
Inclusion Criteria

Online education >6 years <30 years student

Exclusion Criteria

not student not taking online education <6 years >30 years

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Dry eye symptom scale:Tear break up time (TBUT)baseline

Change of tear break up time in distance education

Dry eye scale:Schirmerbaseline

Change of Schirmer in distance education

Dry eye symptom scale: ocular symptom scale index (OSDI)baseline

Change of OSDI in distance education

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Abdullah Beyoğlu

🇹🇷

Kahramanmaraş, In The USA Or Canada, Please Select..., Turkey

Abdullah Beyoğlu
🇹🇷Kahramanmaraş, In The USA Or Canada, Please Select..., Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.